Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AstraZeneca PLC (NYSE:AZN)

27.86
Delayed Data
As of Jun 24
 0.00 / 0.00%
Today’s Change
26.97
Today|||52-Week Range
34.88
-17.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues6.2B5.9B6.3B5.7B
 
 
 
 
 
Cost of Goods Sold287.2M444.9M512.1M400.3M
 
 
 
 
 
Depreciation And Amortization701.8M568.3M706.5M534.6M
 
 
 
 
 
 
Operating ExpensesGross Income5.2B4.9B5.1B4.8B
 
 
 
 
 
General Expenses4.3B4.0B4.1B3.7B
 
 
 
 
 
Other Operating Expenses60.8M55.7M0.000.00
 
 
 
Research And Development1.4B1.4B1.6B1.4B
 
 
 
 
 
Total Operating Expenses5.3B5.0B5.3B4.7B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income879.3M870.8M975.8M1.1B
 
 
 
 
 
Extraordinary Charge-230.4M-213.0M-367.0M-145.6M
 
 
 
 
 
Interest Expense On Debt270.5M244.8M288.1M305.4M
 
 
 
 
 
Equity In Earnings-2.0M-2.0M-6.9M-3.8M
 
 
 
 
 
Other Expenses268.6M515.5M464.7M51.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income646.9M928.6M798.2M683.1M
 
 
 
 
 
Income Taxes-37.2M-160.2M-5.9M-92.1M
 
 
 
 
 
Minority Interest-980.2K0.000.00-19.7M
 
 
 
Net Income683.2M766.3M797.2M607.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.5B2.5B2.5B2.5B
 
 
 
 
 
Shares To Calculate EPS Diluted2.5B2.5B2.5B2.5B
 
 
 
 
 
 
Earnings Per ShareEPS$0.27$0.30$0.31$0.24
 
 
 
 
 
EPS Diluted$0.27$0.30$0.32$0.24